A comparison of buprenorphine induction strategies: Patient-centered home-based inductions versus standard-of-care office-based inductions

Journal of Substance Abuse Treatment

Volumn 40, Issue 4, 2011, Pages 349-356

  Cunningham, Chinazo O ^a,b   Giovanniello, Angela ^a,b   Li, Xuan ^b   Kunins, Hillary V ^a,b   Roose, Robert J ^a,b   Sohler, Nancy L ^a,b,c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

^c CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

Author keywords

Buprenorphine; Buprenorphine induction; Drug use; Opioid; Opioid addiction treatment; Primary care

Indexed keywords

BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; CLONIDINE; IBUPROFEN; LOPERAMIDE; NALOXONE; OPIATE;

ADULT; ANXIETY DISORDER; ARTICLE; COMMUNITY CARE; COMPARATIVE STUDY; DIARRHEA; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; FEMALE; HOME CARE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; PAIN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SELF CARE; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

ADULT; BUPRENORPHINE; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; STANDARD OF CARE; TREATMENT OUTCOME;

EID: 79955092837     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2010.12.002     Document Type: Article

References (39)

1. Alford D.P., LaBelle C.T., Richardson J.M., O'Connell J.J., Hohl C.A., Cheng D.M., et al. Treating homeless opioid dependent patients with buprenorphine in an office-based setting. Journal of General Internal Medicine 2007, 22:171-176.
2. Carrieri M.P., Rey D., Loundou A., Lepeu G., Sobel A., Obadia Y. Evaluation of buprenorphine maintenance treatment in a French cohort of HIV-infected injecting drug users. Drug and Alcohol Dependence 2003, 72:13-21.
3. Center for Substance Abuse Treatment Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction. Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04-3939 2007, Substance Abuse and Mental Health Services Administration, 2004, Rockville, MD.
4. Cicero T.J., Inciardi J.A., Munoz A. Trends in abuse of OxyContin and other opioid analgesics in the United States: 2002-2004. Journal of Pain 2005, 6:662-672.
5. Cunningham C., Giovanniello A., Sacajiu G., Whitley S., Mund P., Beil R., et al. Buprenorphine treatment in an urban community health center: What to expect. Family Medicine 2008, 40:500-506.
6. Cunningham C.O., Kunins H.V., Roose R.J., Elam R.T., Sohler N.L. Barriers to obtaining waivers to prescribe buprenorphine for opioid addiction treatment among HIV physicians. Journal of General Internal Medicine 2007, 22:1325-1329.
7. Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition. (1994) 1994, American Psychiatric Association, Washington, DC.
8. Fiellin D.A. The first three years of buprenorphine in the United States: Experience to date and future directions. Journal of Addiction Medicine 2007, 1:62-67.
9. Fudala P.J., Bridge T.P., Herbert S., Williford W.O., Chiang C.N., Jones K., et al. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. New England Journal of Medicine 2003, 349:949-958.
10. Johnson R.E., Chutuape M.A., Strain E.C., Walsh S.L., Stitzer M.L., Bigelow G.E. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. New England Journal of Medicine 2000, 343:1290-1297.
11. Johnson R.E., Eissenberg T., Stitzer M.L., Strain E.C., Liebson I.A., Bigelow G.E. A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence. Drug and Alcohol Dependence 1995, 40:17-25.
12. Johnson R.E., Jaffe J.H., Fudala P.J. A controlled trial of buprenorphine treatment for opioid dependence. Journal of American Medical Association 1992, 267:2750-2755.
13. Lee J.D., Grossman E., DiRocco D., Gourevitch M.N. Home buprenorphine/naloxone induction in primary care. Journal of General Internal Medicine 2009, 24:226-232.
14. Ling W., Wesson D.R., Charuvastra C., Klett C.J. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Archives of General Psychiatry 1996, 53:401-407.
15. Lott D.C., Strain E.C., Brooner R.K., Bigelow G.E., Johnson R.E. HIV risk behaviors during pharmacologic treatment for opioid dependence: A comparison of levomethadyl acetate [corrected] buprenorphine, and methadone. Journal of Substance Abuse Treatment 2006, 31:187-194.
16. Marsch L.A., Bickel W.K., Badger G.J., Stothart M.E., Quesnel K.J., Stanger C., et al. Comparison of pharmacological treatments for opioid-dependent adolescents: A randomized controlled trial. Archives of General Psychiatry 2005, 62:1157-1164.
17. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom G., et al. The fifth edition of the Addiction Severity Index. Journal of Substance Abuse Treatment 1992, 9:199-213.
18. McLellan A.T., Lewis D.C., O'Brien C.P., Kleber H.D. Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation. Journal of American Medical Association 2000, 284:1689-1695.
19. O'Brien C.P., McLellan A.T. Myths about the treatment of addiction. Lancet. 1996, 347:237-240.
20. O'Connor P.G., Oliveto A.H., Shi J.M., Triffleman E.G., Carroll K.M., Kosten T.R., et al. A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic. American Journal of Medicine 1998, 105:100-105.
21. Olson E.C., Van Wye G., Kerker B., Thorpe L., Frieden T.R. Take care Highbridge and Morrisania. NYC Community Health Profiles, Second Edition (Rep. No. 6 (42)) Available at. http://www.nyc.gov/html/doh/downloads/pdf/data/2006chp-106.pdf.
22. Pani P.P., Maremmani I., Pirastu R., Tagliamonte A., Gessa G.L. Buprenorphine: A controlled clinical trial in the treatment of opioid dependence. Drug and Alcohol Dependence 2000, 60:39-50.
23. Petitjean S., Stohler R., Deglon J.J., Livoti S., Waldvogel D., Uehlinger C., et al. Double-blind randomized trial of buprenorphine and methadone in opiate dependence. Drug and Alcohol Dependence 2001, 62:97-104.
24. Schottenfeld R.S., Pakes J.R., Oliveto A., Ziedonis D., Kosten T.R. Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Archives of General Psychiatry 1997, 54:713-720.
25. Sohler N.L., Li X., Kunins H.V., Sacajiu G., Giovanniello A., Whitley S., et al. Home- versus office-based buprenorphine inductions for opioid-dependent patients. Journal of Substance Abuse Treatment 2010, 38:153-159.
26. Stein M.D., Cioe P., Friedmann P.D. Buprenorphine retention in primary care. Journal of General Internal Medicine 2005, 20:1038-1041.
27. Strain E.C., Stitzer M.L., Liebson I.A., Bigelow G.E. Buprenorphine versus methadone in the treatment of opioid dependence: Self-reports, urinalysis, and addiction severity index. Journal of Clinical Psychopharmacology 1996, 16:58-67.
28. Substance Abuse and Mental Health Services Administration, Office of Applied Studies Results from the 2007 National Survey on Drug Use and Health: National Findings 2008, NSDUH Series H-34, Rockville, MD, (DHHS Publication No. (SMA) 08-4343).
29. Substance Abuse and Mental Health Services Administration, Office of Applied Studies Drug Abuse Warning Network, 2006: National Estimates of Drug-Related Emergency Department Visits 2008, DAWN Series D-30, Rockville, MD, (DHHS Publication No. (SMA) 08-4339).
30. Substance Abuse and Mental Health Services Administration, Office of Applied Studies Treatment Episode Data Set (TEDS). Highlights-2007. National Admissions to Substance Abuse Treatment Services 2009, DASIS Series: S-45, Rockville, MD, (DHHS Publication No. (SMA) 09-4360).
31. Sullivan L.E., Moore B.A., Chawarski M.C., Pantalon M.V., Barry D., O'Connor P.G., et al. Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors. Journal of Substance Abuse Treatment 2008, 35:87-92.
32. Sung H.E., Richter L., Vaughan R., Johnson P.B., Thom B. Nonmedical use of prescription opioids among teenagers in the United States: Trends and correlates. Journal of Adolescent Health 2005, 37:44-51.
33. Turner C.F., Ku L., Rogers S.M., Lindberg L.D., Pleck J.H., Sonenstein F.L. Adolescent sexual behavior, drug use, and violence: Increased reporting with computer survey technology. Science 1998, 280:867-873.
34. Wagner E.H. Chronic disease management: What will it take to improve care for chronic illness?. Effective Clinical Practice 1998, 1:2-4.
35. Wagner E.H., Austin B.T., Davis C., Hindmarsh M., Schaefer J., Bonomi A. Improving chronic illness care: Translating evidence into action. Health Affairs (Millwood.) 2001, 20:64-78.
36. Walley A.Y., Alperen J.K., Cheng D.M., Botticelli M., Castro-Donlan C., Samet J.H., et al. Office-based management of opioid dependence with buprenorphine: Clinical practices and barriers. Journal of General Internal Medicine 2008, 23:1393-1398.
37. Watkins K., Pincus H.A., Tanielian T.L., Lloyd J. Using the Chronic Care Model to improve treatment of alcohol use disorders in primary care settings. Journal of Studies on Alcohol 2003, 64:209-218.
38. Wesson D.R., Ling W. The Clinical Opiate Withdrawal Scale (COWS). Journal of Psychoactive Drugs 2003, 35:253-259.
39. Whitley S.D., Sohler N.L., Kunins H.V., Giovanniello A., Li X., Sacajiu G., et al. Factors associated with complicated inductions. Journal of Substance Abuse Treatment 2010, 39:51-57.